News Articles for OncoSil Medical

Research skills not matched by returns

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

SPECIAL REPORT: Despite WA's history of innovative medical research, the state's medtech sector continues to grapple with outsider perceptions and its own commercial direction.

Investors turn to innovation

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

FEATURE: Biotech and IT companies are enjoying renewed investor interest, but these innovative businesses are facing a changing capital raising market featuring less government support and, in Perth, a drastic shift in the venture capital sector.

Market chemistry grows biotech deals

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

SPECIAL REPORT: The biotech sector came to life in 2013 but pricing was critical to the success or failure of capital raisings.

Rogers to NeuroDiscovery

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Consegna Group chairman Martin Rogers has joined NeuroDiscovery as deputy chairman. Mr Rogers is a current non-executive director and former chief executive of Prima BioMed.

NeuroDiscovery acquires UK biotech

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based biotech company NeuroDiscovery is taking a punt on radiotherapy technology being developed in the United Kingdom.

NeuroDiscovery sign largest ever deal

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based neurology focused research and development company NeuroDiscovery has entered a specialist services deal with a major international pharmaceutical company, valued at $620,000, the company's largest every contract.

NeuroDiscovery Ltd trials new chronic pain relievers

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based research and development company NeuroDiscovery Ltd is set to launch two clinical trials on new chronic pain relievers.

NeuroDiscovery completes Phase 1 of drug trials

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based neurology research company NeuroDiscovery Ltd will seek approval from the British Medicines and Healthcare products Regulatory Agency to extend trials of neuropathic pain treatment NSL-043 to higher doses, after the first phase of trials was c

Millipede, NeuroDiscovery bolster working capital funds

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Two Perth-based companies have announced successful captial raising to boost their working capital funds.

NeuroDiscovery raises $3.2m for pain trials

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based neurology research company NeuroDiscovery Ltd has announced plans to raise $3.2 million through a share issue and share purchase plan to fund further human trials of its pain-treatment drugs.

NeuroDiscovery Ltd - 11/04/2006

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

1,350,000 fully paid ordinary shares will be released from escrow on 20 April 2006

NeuroDiscovery Ltd

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

NeuroDiscovery Ltd 15-Aug-05 David Spanswick became a substantial shareholder with a relevant interest of 2,389,495 ordinary shares (6.55%).

NeuroDiscovery Ltd

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

NeuroDiscovery Ltd 15-Aug-05 Fei Yue Zhao became a substantial shareholder with a relevant interest of 2,389,495 ordinary shares (6.55%).

NeuroDiscovery Ltd

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

NeuroDiscovery Ltd 15-Aug-05 Kevin Lee became a substantial shareholder with a relevant interest of 2,389,495 ordinary shares (6.55%).

NeuroDiscovery Ltd

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

NeuroDiscovery Ltd 15-Aug-05 Margaret Livingston became a substantial shareholder with a relevant interest of 2,375,000 ordinary shares (6.61%).

NeuroDiscovery Ltd

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

NeuroDiscovery Ltd 15-Aug-05 Sartino Di Giacomo became a substantial shareholder with a relevant interest of 1,875,000 ordinary shares (6.14%).

NeuroDiscovery Ltd

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

NeuroDiscovery Ltd 15-Aug-05 Mark Treherne became a substantial shareholder with a relevant interest of 2,389,495 ordinary shares.